Erenumab (AMG 334) Key Clinical Trials By The Numbers

Restricted

Description

Erenumab has been studied in several large, global, randomized, double-blind, placebo-controlled studies to assess its safety and efficancy in migraine prevention.  

Usage Rights & Restrictions

This media asset is free for editorial broadcast, print, online and radio use. It is restricted for other purposes.

Request Access to Download

This file is for journalists only. Please fill out the form below to request access.

By submitting this field I verify that I am a journalist.